Literature DB >> 11884770

Diffuse pulmonary neuroendocrine cell hyperplasia: radiologic and clinical features.

Jin Seong Lee1, Kevin K Brown, Carlyne Cool, David A Lynch.   

Abstract

PURPOSE: The purpose of this study was to define the radiologic features of pulmonary neuroendocrine cell hyperplasia and correlate them with clinical findings.
METHOD: Five women, ranging in age from 45 to 63 years, were diagnosed with pulmonary neuroendocrine cell hyperplasia. Two radiologists assessed the presence and extent of airway wall thickening, mosaic pattern, air trapping, ground-glass opacity, nodular opacity, and centrilobular opacity on high resolution CT. The CT findings were compared with physiologic data and histologic features.
RESULTS: On CT scans, mosaic pattern was the predominant finding in all patients. The extent of mosaic pattern was correlated with the forced expiratory volume in 1 s/forced vital capacity ratio (r = 0.8508, p = 0.0317). Nodular lesions were noted in three patients. Airway walls were thickened in four patients. In one patient, ground-glass opacity and centrilobular opacity were also noted on high resolution CT.
CONCLUSION: Pulmonary neuroendocrine cell hyperplasia is characterized by mosaic perfusion due to air trapping, airway wall thickening, and occasional small nodules on high resolution CT scans. The extent of mosaic perfusion correlates with physiologic evidence of airway obstruction.

Entities:  

Mesh:

Year:  2002        PMID: 11884770     DOI: 10.1097/00004728-200203000-00003

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  7 in total

1.  [A 74-year-old female patient with histologically proven carcinoid of the lungs and pulmonary mosaic pattern].

Authors:  B Greiner; C Schulz; M Pfeifer; P Heiss; M Völk; S Feuerbach; O W Hamer
Journal:  Radiologe       Date:  2009-06       Impact factor: 0.635

Review 2.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

3.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.

Authors:  Hanako Oba; Kazunori Nishida; Shingo Takeuchi; Hirohiko Akiyama; Koji Muramatsu; Masafumi Kurosumi; Toru Kameya
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

4.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series.

Authors:  Aman Chauhan; Robert A Ramirez
Journal:  Lung       Date:  2015-06-26       Impact factor: 2.584

5.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Authors:  Susan J Davies; John R Gosney; David M Hansell; Athol U Wells; Roland M du Bois; Margaret M Burke; Mary N Sheppard; Andrew G Nicholson
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

Review 6.  Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.

Authors:  Jean-François Cordier
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

7.  A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report.

Authors:  Masafumi Yamaguchi; Fumihiko Hirai; Kenichi Taguchi; Ryo Toyozawa; Makoto Edagawa; Shinichiro Shimamatsu; Kaname Nosaki; Takashi Seto; Mitsuhiro Takenoyama; Yukito Ichinose
Journal:  Surg Case Rep       Date:  2017-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.